 Forbes | FDA approves pump for heart failure patients awaiting heart transplant FDA.gov The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant. FDA approves HeartWare Ventricular Assist System to treat end-stage heart failure FDA approves HeartWare heart pump; shares leap FDA approves HeartWare pump for heart failure patients |
